Caspase-dependent Cdk activity is a requisite effector of apoptotic death events

Journal of Cell Biology

Volumn 148, Issue 1, 2000, Pages 59-72

  Harvey, Kevin J ^a   Lukovic, Dunja ^a   Ucker, David S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Apoptosis; Caspase; Cdk2; Mitochondria; Physiological cell death

Indexed keywords

CASPASE; CYCLIN DEPENDENT KINASE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MOLECULAR DYNAMICS; PRIORITY JOURNAL;

APOPTOSIS; CASPASES; CDC2-CDC28 KINASES; CHROMATIN; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; HELA CELLS; HUMANS; MITOCHONDRIA; PROTEIN-SERINE-THREONINE KINASES;

EID: 0034627832     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.148.1.59     Document Type: Article

References (106)

1. Adams, P.D., W.R. Sellers, S.K. Sharma, A.D. Wu, C.M. Nalin, and W.G.J. Kaelin. 1996. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16: 6623-6633.
2. Al-Ubaidi, M.R., J.G. Hollyfield, P.A. Overbeek, and W. Bachr. 1992. Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. Proc. Natl. Acad. Sci. USA. 89: 1194-1198.
3. Blasina, A., E.S. Paegle, and C.H. McGowan. 1997. The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells. Mol. Biol. Cell. 8:1013-1023.
4. Boise, L.H., M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nuñez, and C.B. Thompson. 1993. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74: 597-608.
5. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 377:552-557.
6. Chen, J., P.K. Jackson, M.W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature. 374:386-388.
7. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
8. L function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271:4573-4576.
9. Dbaibo, G.S., D.K. Perry, C.J. Gamard, R. Platt, G.G. Poirier, L.M. Obeid, and Y.A. Hannun. 1997. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185:481-490.
10. Diehl, J.A., and C.J. Sherr. 1997. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol. 17:7362-7374.
11. Ellis, H.M., and H.R. Horvitz. 1986. Genetic control of programmed cell death in the nematode C. elegans. Cell. 44:817-829.
12. Emoto, Y., Y. Manome, G. Meinhardt, H. Kisaki, S. Kharhanda, M. Robertson, T. Ghayur, W.W. Wong, R. Kamen, R. Weichselbaum, and D. Kufe. 1995. Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO (Eur. Mol. Biol. Organ.) J. 14:6148-6156.
13. Enari, M., A. Hase, and S. Nagata. 1995. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO (Eur. Mol. Biol. Organ.) J. 14:5201-5208.
14. Enari, M., R.V. Talanian, W.W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:723-726.
15. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNasc that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:43-50.
16. Fadok, V.A., D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
17. Farkas, D.L., M.-d. Wei, P. Febbroriello, J.H. Carson, and L.M. Loew. 1989. Simultaneous imaging of cell and mitochondrial membrane potentials. Biophys. J. 56:1053-1069.
18. Feddersen, R.M., R. Ehlenfeldt, W.S. Yunis, H.B. Clark, and H.T. Orr. 1992. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice. Neuron. 9:955-966.
19. Fernandes-Alnemri, T., R.C. Armstrong, J. Krebs, S.M. Srinivasula, L. Wang, F. Bullrich, L.C. Fritz, J.A. Trapani, K.J. Tomaselli, G. Litwack, and E.S. Alnemri. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA. 93:7464-7469.
20. Fotedar, R., J. Flatt, S. Gupta, R.L. Margolis, P. Fitzgerald, H. Messier, and A. Fotedar. 1995. Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Mol. Cell. Biol. 15:932-942.
21. 1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157:4309-4315.
22. 2 phase arrest. J. Biol. Chem. 274:13961-13969.
23. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature. 382:511-517.
24. Cip1/Waf1 event during DNA damage-induced apoptosis. J. Biol. Chem. 273:19207-19212.
25. Glab, N., B. Labidi, L.-X. Qin, C. Trehin, C. Bergounioux, and L. Meijer. 1994. Olomoucine, an inhibitor of cdc2/cdk2 kinase activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions. FEBS Lett. 353:207-211.
26. Gromkowski, S.H., T.C. Brown, P.A. Cerutti, and J.-C. Cerottini. 1986. DNA of human Raji target cells is damaged upon lymphocyte-mediated lysis. J. Immunol. 136:752-756.
27. Hakem, A., T. Sasaki, I. Kozieradzki, and J.M. Penninger. 1999. The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis. J. Exp. Med. 189:957-967.
28. Harvey, K.J., J.F. Blomquist, and D.S. Ucker. 1998. Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2, caspase, and cyclin-dependent kinase activities. Mol. Cell. Biol. 18: 2912-2922.
29. Heald, R., M. McLoughlin, and F. McKeon. 1993. Human Wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell. 74:463-474.
30. Hendzel, M.J., W.K. Nishioka, Y. Raymond, C.D. Allis, D.P. Bazett-Jones, and J.P.H. Th'ng. 1998. Chromatin condensation is not associated with apoptosis. J. Biol. Chem. 273:24470-24478.
31. Hengartner, M.O., and H.R. Horvitz. 1994. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 76:665-675.
32. Hengartner, M.O., R.E. Ellis, and H.R. Horvitz. 1992. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature. 356:494-499.
33. Hirano, M., R. Kobayashi, and T. Hirano. 1997. Condensins, chromosome condensation protein complexes containing XCAP-C, XCAP-E, and a Xenopus homolog of the Drosophila Barren protein. Cell. 89:511-521.
34. Hirata, H., A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai, T. Okazaki, K. Yamamoto, and M. Sasada. 1998. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187:587-600.
35. Hockenbery, D., G. Nuñez, C. Milliman, R.D. Schreiber, and S.J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:334-336.
36. Howell, D.M., and E. Martz. 1987. The degree of CTL-induced DNA solubilization is not determined by the human vs mouse origin of the target cell. J. Immunol. 138:3695-3698.
37. Jiang, W., and T. Hunter. 1998. Analysis of cell-cycle profiles in transfected cells using a membrane-targeted GFP. Biotechniques 24:348-354.
38. Jin, P., S. Hardy, and D.O. Morgan. 1998. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141:875-885.
39. Kerr, J.F.R., A.H. Wyllie, and A.R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:239-256.
40. Kimura, K., M. Hirano, R. Kobayashi, and T. Hirano. 1998. Phosphorylation and activation of 13S condensin by Cdc2 in vitro. Science. 282:487-490.
41. Kip1. Cell. 85:721-732.
42. Kluck, R.M., E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132-1136.
43. Krishan, A. 1975. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66:188-193.
44. Lazebnik, Y.A., A. Takahashi, R.D. Moir, R.D. Goldman, G.G. Poirier, S.H. Kaufmann, and W.C. Earnshaw. 1995. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA. 92:9042-9046.
45. Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell. 1:553-563.
46. Li, F., G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:5811-584.
47. Li, P., D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:479-489.
48. Kip1. Mol. Cell. Biol. 16:6744-6751.
49. MacFarlane, M., K. Cain, X.-M. Sun, E.S. Alnemri, and G.M. Cohen. 1997. Processing/activation of at least four interleukin-1β converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J. Cell Biol. 137:469-479.
50. Marchetti, P., T. Hirsch, N. Zamzami, M. Castedo, D. Decaudin, S.A. Susin, B. Masse, and G. Kroemer. 1996. Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol. 157:4830-4836.
51. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
52. Meikrantz, W., S. Gisselbrecht, S.W. Tam, and R. Schlegel. 1994. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA. 91:3754-3758.
53. Meikrantz, W., and R. Schlegel. 1996. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J. Biol. Chem. 271: 10205-10209.
54. Mcmon, S.A., M.B. Moreno, D. Petrak, and C.M. Zacharchuk. 1995. Bcl-2 blocks glucocorticoid - but not Fas - or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644-4652.
55. Meyerson, M., G.H. Enders, C-L. Wu, L.-K. Su, C. Gorka, C. Nelson, E. Harlow, and L.-H. Tsai. 1992. A family of human cdc2-related protein kinases. EMBO (Eur. Mol. Biol. Organ.) J. 11:2909-2917.
56. L. J. Biol. Chem. 271:6306-6312.
57. Munger, K., B.A. Werness, N. Dyson, W.C. Phelps, E. Harlow, and P.M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblasloma tumor suppressor gene product. EMBO (Eur. Mol. Biol. Organ.) J. 8:4099-4105.
58. Nicholson, D.W., A. Ali, N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, M. Gallant, Y. Gareau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:37-43.
59. Oltvai, Z.N., and S.J. Korsmeyer. 1994. Checkpoints of dueling dimers foil death wishes. Cell. 79:189-192.
60. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell. 74:609-619.
61. Packard, B.Z., D.D. Toptygin, A. Komoriya, and L. Brand. 1996. Profluorescent proteasc substrates: intramolecular dimers described by the exciton model. Proc. Natl. Acad. Sci. USA. 93:11640-11645.
62. Park, D.S., E.J. Morris, J. Padmanabhan, M.L. Shelanski, H.M. Geller, and L.A. Greene. 1998. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J. Cell Biol. 143:457-467.
63. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:59-66.
64. Radvanyi, L.G., Y. Shi, G.B. Mills, and R.G. Miller. 1996. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis. Cell. Immunol. 170:260-273.
65. Rao, L., D. Perez, and E. White. 1996. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135:1441-1455.
66. Rao, P.N., and J. Engelherg. 1966. Effects of temperature on the mitotic cycle of normal and synchronized mammalian cells. In Cell Synchrony: Studies in Biosynthetic Regulation. I.L. Cameron and G.M. Padilla, editors. Academic Press, New York.
67. Riabowol, K., G. Dractta, L. Brizuela, D. Vandre, and D. Beach. 1989. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell. 57:393-401.
68. Robles, S.J., P. Shiyanov, G.T. Aristodemo, P. Raychaudhuri, and G.R. Adami. 1998. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes. DNA Cell Biol. 17:9-18.
69. Russell, J.H., V.R. Masakowski, and C.B. Dobos. 1980. Mechanisms of immune lysis 1. Physiological distinction between target cell death mediated by cytotoxic T lymphocytes and antibody plus complement. J. Immunol. 124:1100-1105.
70. . , a gene encoding a protein kinase homolog. Cell. 49:559-567.
71. Sakahira, H., M. Enari, and S. Nagata. 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:96-99.
72. Salvesen, G.S., and V.M. Dixit. 1997. Caspases: intracellular signaling by proteolysis. Cell. 91:443-446.
73. Samejima, K., S. Toné, T.J. Kottke, M. Enari, H. Sakahira, C.A. Cooke, F. Durrieu, L.M. Martins, S. Nagala, S.H. Kaufmann, and W.C. Earnshaw. 1998. Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution. J. Cell Biol. 143:225-239.
74. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat. Med. 3:313-319.
75. KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene. 18:1663-1676.
76. Serrano, M., H.-W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:27-37.
77. Shaham, S., and H.R. Horvitz. 1996. Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Devel. 10:578-591.
78. cdc2 activation required for apoptosis. Science. 263:1143-1145.
79. Shi, L., G. Chen, D. He, D.G. Bosc, D.W. Litchfield, and A.H. Greenberg. 1996. Granzyme B induces apoptosis and cyclin A-associated cyclin-dependent kinase activity in all stages of the cell cycle. J. Immunol. 157:2381-2385.
80. Slee, E.A., M.T. Harte, R.M. Kluck, B.B. Wolf, C.A. Casiano, D.D. Newmeyer, H.-G. Wang, J.C. Reed, D.W. Nicholson, E.S. Alnemri, et al. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:281-292.
81. cdc2. Cell. 63:1013-1024.
82. Strasser, A., A.W. Harris, D.C.S. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis EMBO (Eur. Mol. Biol. Organ.) J. 14:6136-6147.
83. cdc2/ cyclin B complex in vitro by human cdc25 protein. Nature. 351:242-245.
84. Susin, S.A., N. Zamzami, M. Castedo, E. Daugas, H.-G. Wang, S. Geley, F. Fassy, J.C. Reed, and G. Kroemer. 1997. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186:25-37.
85. Susin, S.A., H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, et al. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:441-445.
86. Tewari, M., L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D.R. Beidler, G.G. Poirier, G.S. Salvesen, and V.M. Dixit. 1995. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly( ADP-rihose) polymerase. Cell. 81:801-809.
87. Thornberry, N.A., H.G. Bull, J.R. Calaycay, K.T. Chapman, A.D. Howard, M.J. Kostura, D.K. Miller, S.M. Molineaux, J.R. Weidner, J. Aunins, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature. 356:768-774.
88. Thornberry, N.A., T.A. Rano, E.P. Peterson, D.M. Rasper, T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom, S. Roy, J.P. Vaillancourt, et al. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272:17907-17911.
89. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:67-74.
90. Ucker, D.S. 1991. Death by suicide: one way to go in mammalian cellular development? New Biol. 3:103-109.
91. Ucker, D.S. 1997. Death and dying in the immune system. In Apoptosis: Pharmacological Implications and Therapeutic Opportunities. Advances in Pharmacology ed., vol. 41, ed. S.H. Kaufmann. Academic Press, New York.
92. Ucker, D.S., P.S. Obermiller, W. Eckhart, J.R. Apgar, N.A. Berger, and J. Meyers. 1992. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol. Cell. Biol. 12:3060-3069.
93. Van de Craen, M., P. Vandenabeele, W. Declercq, I. Van den Brande, G. Van Loo, F. Molemans, P. Schotte, W. Van Criekinge, R. Beyaert, and W. Fiers. 1997. Characterization of seven murine caspase family members. FEBS Lett. 403:61-69.
94. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:2050-2054.
95. Vaux, D.L., I.L. Weissman, and S.K. Kim. 1992. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science. 258:1955-1957.
96. Wang, Z.-O., B. Auer, L. Stingl, H. Berghammer, D. Haidacher, M. Schweiger, and E.F. Wagner. 1995. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Devel. 9:509-520.
97. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:555-556.
98. Xue, D., S. Shaham, and H. R. Horvitz. 1996. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Devel. 10:1073-1083.
99. Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.-I. Peng, D.P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1129-1132.
100. Yasuhara, N., Y. Eguchi, T. Tachibana, N. Imamoto, Y. Yoneda, and Y. Tsujimoto. 1997. Essential role of active nuclear transport in apoptosis. Genes Cells. 2:55-64.
101. Yuan, J., S. Shaham, S. Ledoux, H.M. Ellis, and H.R. Horvitz. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:641-652.
102. Zamzami, N., S.A. Susin, P. Marchetti, T. Hirsch, I. Gómez-Monterrey, M. Castedo, and G. Kroemer. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533-1544.
103. Zhang, J., X. Liu, D.C. Scherer, L. van Kaer, X. Wang, and M. Xu. 1998. Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. Proc: Natl. Acad. Sci. USA. 95:12480-12485.
104. Wafl/Cipl cancer cells from growth arrest to undergoing apoptosis. Oncogene. 18:1131-1138.
105. Zhou, B.-B., H. Li, J. Yuan, and M.W. Kirschner. 1998. Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc. Natl. Acad. Sci. USA. 95:6785-6790.
106. Zou, H., W.J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:405-413.